RITTER PHARMACEUTICALS INC (RTTR) has 15 open-market insider trades by 7 insiders since 2015. The most active filer is Matthew W. Foehr, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Noah Doyle | Dir | — | 2 | $4.1M | 2020-03-12 |
| Javelin Venture Partners, L.P. | 10% Owner | — | 1 | $4.0M | 2017-10-03 |
| Gerald T. Proehl | Dir | — | 1 | $250K | 2015-06-24 |
| Matthew W. Foehr | Dir | — | 4 | $93K | 2020-04-10 |
| Michael D. Step | CEO | — | 3 | $75K | 2017-05-11 |
| Andrew J. Ritter | Pres | — | 2 | $17K | 2020-03-04 |
| Ira E. Ritter | CSOCOB | — | 2 | $17K | 2020-03-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Noah Doyle | Director | Sell | $110K | 2020-03-12 |
| Andrew J. Ritter | President | Sell | $7K | 2020-03-04 |
| Matthew W. Foehr | Director | Buy | $40K | 2018-08-17 |
| Matthew W. Foehr | Director | Buy | $11K | 2017-05-18 |
| Michael D. Step | CEO | Buy | $8K | 2017-05-11 |
| Michael D. Step | CEO | Buy | $26K | 2017-02-27 |
Companies that share insiders with RTTR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ira E. Ritter | Chairman & CSO +1 | Buy | $10K | 2016-02-22 |
| Matthew W. Foehr | Director | Buy | $21K | 2016-01-08 |
| Michael D. Step | CEO | Buy | $40K | 2016-01-07 |
| Javelin Venture Partners, L.P. | 10% | Buy | $4.0M | 2015-06-24 |
| Gerald T. Proehl | Director | Buy | $250K | 2015-06-24 |
| Matthew W. Foehr | Director | Buy | $20K | 2015-06-24 |